Effect of Mimetic CDK9 Inhibitors on HIV-1-Activated Transcription.

Authors

Rachel Van Duyne, George Washington University
Irene Guendel, George Mason University
Elizabeth Jaworski, George Mason University
Gavin Sampey, George Mason University
Zachary Klase, National Institutes of Health, Bethesda, MD
Hao Chen, George Washington University
Chen Zeng, Arizona State University
Dmytro Kovalskyy, Institute of Molecular Biology and Genetics, Kiev, UkraineFollow
Mahmoud H. El Kouni, University of Alabama at Birmingham, Birmingham, AL
Benjamin Lepene, Ceres Nanosciences, Inc., Manassas, VA
Alexis Patanarut, Ceres Nanosciences, Inc., Manassas, VA
Sergei Nekhai, Howard University
David H. Price, University of Iowa
Fatah Kashanchi, George Washington University

Document Type

Journal Article

Publication Date

2-22-2013

Journal

Journal of Molecular Biology

Volume

Volume 425, Issue 4

Inclusive Pages

812-829

Keywords

Cyclin-Dependent Kinase 9--antagonists & inhibitors; HIV-1--drug effects; Protein Kinase Inhibitors--pharmacology; Transcriptional Activation--drug effects

Comments

This is an open access PubMed Central article. Click on link for full-text access.

APA Citation

Van Duyne, R., Guendel, I., Jaworski, E., Sampey, G., Klase, Z., Chen, H., . . . Kashanchi, F. (2013). Effect of mimetic CDK9 inhibitors on HIV-1-activated transcription. Journal of Molecular Biology, 425(4), 812-829.

Peer Reviewed

1

Open Access

1